September 1, 2010 | New York Times
Finding Suggests New Target for Alzheimer’s Drugs
The front page of the New York Times online featured an interview with Nobel laureate Dr. Paul Greengard by journalist Gina Kolata on his recent breakthrough Alzheimer’s research finding. In the article, Kolata also interviewed Dr. Paul Aisen from the University of California, San Diego, Dr. Rudolph Tanzi, from Harvard Medical School, and Dr. Sangram S. Sisodia, from the University of Chicago, in “Finding Suggests New Target for Alzheimer’s Drugs”, asking how this research will impact future Alzheimer’s treatment. Click here for the full article
September 1, 2010 | science news
Scientists identify protein that spurs formation of Alzheimer’s plaques
In Alzheimer’s disease, the problem is beta-amyloid, a protein that accumulates in the brain and causes nerve cells to weaken and die. Drugs designed to eliminate plaques made of beta-amyloid have a fatal problem: they need to enter the brain and remove the plaques without attacking healthy brain cells. A new breakthrough from the laboratory of Nobel Prize winner Paul Greengard, however, suggests that treatments modeled on the blockbuster cancer drug Gleevec could be the solution.
July 27, 2010 | science news
MicroRNAs play a role in cocaine addiction
MicroRNAs, short stretches of RNA that silence genes, have already been linked to cancer, heart disease and mental disorders such as schizophrenia. New research by Rockefeller University scientists suggests microRNAs are also involved in regulating the motivation to consume cocaine, a finding that could ultimately lead to new ways of combating addictive diseases in humans.
June 10, 2010 | science news
Alzheimer’s brain protein may provide target for treating mental retardation
Reducing the level of β-amyloid, a protein found in the brains of patients with Alzheimer’s disease and Down syndrome, may improve the cognitive abilities of children with Down syndrome. The new study by Rockefeller University scientists may provide a model for developing new anti-amyloid drugs.
Click here for full news listing from The Rockefeller University